Agrigenomics Market Growth Analysis, Dynamics, Key Players and Innovations, Outlook and Forecast 2025-2032

According to a new report from Intel Market Research, the global Agrigenomics market was valued at USD 4736 million in 2024 and is projected to reach USD 7487 million by 2032, growing at a robust CAGR of 6.9% during the forecast period (2025–2032). This growth is propelled by increasing global demand for food security, advancements in genomic technologies, and the integration of big data in agriculture.

What is Agrigenomics?

Agrigenomics is the application of genomics in agriculture to improve crop yields, livestock health, and sustainable farming practices. It includes a wide range of products and scientific services including DNA extraction and purification, DNA/RNA sequencing, genotyping, gene expression profiling, marker-assisted selection, GMO/trait purity testing, and other related technologies.

The market is characterized by high technological intensity and serves both crop and livestock sectors. Major industry players include Thermo Fisher Scientific, Illumina, Agilent Technologies, Eurofins, and Zoetis, who collectively hold about 40% market share. North America accounts for approximately 50% of the global market.

Key Market Drivers

1. Increasing Global Food Demand

With the global population projected to reach 9.7 billion by 2050, ensuring food security has become a priority. Agrigenomics enables precision agriculture through genetic insights, allowing farmers to optimize yields and reduce losses.

2. Technological Advancements in Genomics

The cost of DNA sequencing has dropped dramatically over the past decade, making genomic applications more accessible. Next-generation sequencing (NGS), CRISPR, and other gene-editing technologies are being increasingly adopted in agriculture.

3. Climate Change and Sustainable Agriculture

Climate-resilient crops and sustainable livestock management require genetic insights. Agrigenomics helps develop crops that withstand drought, pests, and diseases while optimizing resource utilization.

Market Challenges

  • High implementation costs: Advanced genomic technologies require significant investment in equipment, training, and infrastructure, making adoption challenging in developing regions.
  • Regulatory complexity: Genetically modified organisms (GMOs) face varying regulatory landscapes across countries, creating market access barriers.
  • Data interpretation challenges: The vast amount of data generated requires sophisticated bioinformatics tools and expertise, which are not universally available.

Market Segmentation

By Product Type

  • Illumina HiSeq
  • Sanger Sequencer
  • PacBio Sequencer
  • SOLiD Sequencer
  • Others (including microarray, PCR, etc.)

By Application

  • Crops
  • Livestock

By Region

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Benelux, Rest of Europe)
  • Asia (China, Japan, South Korea, Southeast Asia, India, Rest of Asia)
  • South America (Brazil, Argentina, Rest of South America)
  • Middle East & Africa (Turkey, Israel, Saudi Arabia, UAE, Rest of Middle East & Africa)

Regional Market Insights

North America leads the global market, accounting for approximately 50% of revenue. This is attributed to high technology adoption rates, strong R&D investments, and the presence of major market players.

Europe follows closely, with strong research initiatives and government support for agricultural innovation.

Asia-Pacific is expected to be the fastest-growing market due to increasing population, rising food demand, and growing adoption of advanced agricultural practices.

Competitive Landscape

The market is moderately consolidated with key players including:

  • Thermo Fisher Scientific
  • Illumina Inc.
  • Agilent Technologies
  • Eurofins Scientific
  • Zoetis Inc.
  • LGC Limited
  • BGI Group
  • Neogen Corporation
  • Pacific Biosciences
  • CEN4GEN Institute
  • NuGEN Technologies
  • Edico Genome
  • UD-GenoMed Limited
  • SciGenom

These companies compete based on product quality, pricing, technological innovation, and after-sales services. Recent developments include partnerships between agribusiness giants and genomics companies to develop integrated solutions.

Future Outlook

The Agrigenomics market is poised for continued growth due to:

  • Integration with AI and machine learning: Advanced data analytics will enhance predictive capabilities in agriculture.
  • Precision agriculture expansion: IoT and sensor technologies will generate more data, driving demand for genomic analysis.
  • Emerging market growth: Countries in Asia, Latin America, and Africa are increasingly adopting advanced agricultural technologies.

Research Methodology

This report is based on extensive primary research (surveys and interviews with key industry players) and secondary research (industry reports, company publications, market databases). Market size estimates consider revenue generated by companies from product sales and service offerings.

📥 Download Sample Report: Agrigenomics Market - Download Free Sample

About Intel Market Research

Intel Market Research is a leading provider of strategic intelligence, offering actionable insights in biotechnology, pharmaceuticals, and healthcare infrastructure. Our research capabilities include:

  • Real-time competitive benchmarking
  • Global clinical trial pipeline monitoring
  • Country-specific regulatory and pricing analysis
  • Over 500+ healthcare reports annually

Trusted by Fortune 500 companies, our insights empower decision-makers to drive innovation with confidence.

🌐 Website: https://www.intelmarketresearch.com
📞 International: +1 (332) 2424 294
Asia-Pacific: +91 9169164321
🔗 LinkedIn: Follow Us

Comments

Post a Comment

Popular posts from this blog

Physical Security Information Management (PSIM) Market Growth Analysis, Dynamics, Key Players and Innovations, Outlook and Forecast 2025-2032

 According to a new report from Intel Market Research, the global Physical Security Information Management (PSIM) market was valued at USD 2665 million in 2024 and is projected to reach USD 8847 million by 2032, growing at a robust CAGR of 19.2% during the forecast period (2025-2032). This growth is propelled by the increasing demand for integrated security solutions across critical infrastructure, commercial facilities, and government facilities. What is Physical Security Information Management (PSIM)? Physical Security Information Management (PSIM) is a category of software that provides a platform and applications created by middleware developers, designed to integrate multiple unconnected security applications and devices and control them through one comprehensive user interface. Beyond the time-saving and efficiency benefits of automation, PSIM enables modern business processes that are essential to any modern security department. For organizations, this includes regular rep...
Read more

AI In Telecommunication Market Growth Analysis, Dynamics, Key Players and Innovations, Outlook and Forecast 2025-2032

 According to a new report from Intel Market Research , the global AI in Telecommunication market was valued at USD 2.267 billion in 2024 and is projected to reach USD 27.55 billion by 2032 , growing at an extraordinary CAGR of 44.0% during the forecast period (2025–2032). This explosive growth is driven by increasing network complexity, rising demand for enhanced customer experiences, and the critical need for operational efficiency in telecommunications infrastructure worldwide. What is AI in Telecommunication? AI in Telecommunication refers to the integration of artificial intelligence technologies into telecommunications networks and services to optimize operations, enhance security, and improve customer engagement. These technologies enable telecom operators to transform from traditional connectivity providers into intelligent, data-driven service platforms. The implementation spans various AI technologies including machine learning algorithms , deep neural networks , and ...
Read more

Medical Carts Market Growth Analysis, Dynamics, Key Players and Innovations, Outlook and Forecast 2025-2032

 According to a new report from Intel Market Research , the global Afamelanotide market was valued at USD 136.27 million in 2024 and is projected to reach USD 258.01 million by 2032 , growing at a robust CAGR of 9.1% during the forecast period (2025–2032). This growth is propelled by the increasing global prevalence of rare phototoxic disorders, heightened awareness about orphan diseases, and advancements in melanocortin-based peptide therapies. What is Afamelanotide? Afamelanotide is a first-in-class synthetic analog of α-MSH (alpha-melanocyte-stimulating hormone) , a naturally occurring hormone responsible for skin pigmentation and immune modulation. The drug is primarily indicated for Erythropoietic Protoporphyria (EPP) —a rare, inherited disorder characterized by severe phototoxic reactions to sunlight. Afamelanotide acts by stimulating melanin production, thereby enhancing photoprotection and significantly improving quality of life for patients. Marketed under the brand na...
Read more